Annual Drug Patent Expirations for XADAGO
Xadago is a drug marketed by Mdd Us and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has eigthy patent family members in thirty-one countries.
The generic ingredient in XADAGO is safinamide mesylate. One supplier is listed for this compound. Additional details are available on the safinamide mesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com